Ana Krtolica is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of cancer treatment through her innovative research and development. Her work focuses on modulating tumor immunity, which is crucial for advancing cancer therapies.

Latest Patents

Ana Krtolica holds a patent for her invention titled "Modulation of tumor immunity by protein-mediated Odelivery." This invention provides methods to modulate hypoxia-mediated tumor immunity by administering an Ocarrier polypeptide, such as an H-NOX protein. The methods target both hypoxia-inducible factor 1 alpha (HIF-1α) pathways and non-HIF-1α pathways of tumor immunity. Such methods are useful in treating a wide variety of cancers and may be used alone or in combination with other anti-cancer therapies. She has 1 patent to her name.

Career Highlights

Ana Krtolica is currently associated with Omniox, Inc., where she continues her groundbreaking work in cancer research. Her innovative approaches have the potential to change the landscape of cancer treatment and improve patient outcomes.

Collaborations

Ana collaborates with notable colleagues, including Stephen P L Cary and Natacha Le Moan. These partnerships enhance her research and contribute to the development of effective cancer therapies.

Conclusion

Ana Krtolica is a trailblazer in the field of tumor immunity modulation, with her innovative patent paving the way for new cancer treatments. Her work exemplifies the impact of scientific research on healthcare advancements.

Profile summary based on public USPTO records.